Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEV90 of Ropivacaine for TQL Block in PNL
NCT04196270Phase 4Unknown
- Sponsor
- Zealand University Hospital
- Start
- Jan 2020
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of ropivacaine in nephrolithiasis, sponsored by Zealand University Hospital. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT04196270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04196270.